Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Aug 16, 2004


In the 08-09-04 issue of BioInform, the article, “With Bayer Deal Gone, Lion’s Revenues Set to Continue Sliding; Cost Cutting Expected,” contained several errors. The company’s current products are SRS and Lion Target Engine. Lion no longer sells Lion Discovery Center. In addition, the article reported that Lion’s “order backlog” has been improving instead of its “order pipeline.”

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.